The purpose of this study is to investigate how the investigational medication moves through the bodies of pregnant women who have hepatitis C compared to those who do not. Hepatitis C is a liver infection caused by the hepatitis C virus, and pharmacokinetics is the study of how a drug is absorbed, distributed, metabolized, and eliminated by the body.
Participants in this study will undergo procedures that help researchers understand the medication's effects on their bodies. This could involve blood tests and monitoring to measure how the drug is processed and how it behaves in the body.
- Who can participate: Pregnant women of any age with or without hepatitis C infection may be eligible to participate. Specific eligibility criteria were not provided.
- Study details: Participants will be required to take the investigational medication and may have to undergo blood tests to monitor how the medication is processed in their bodies.
